Nicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development Update

Press ReleaseNicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development Update More patients on NCX 470 achieve an intraocular pressure (IOP) of less than or equal to 18 mmHg compared to latanoprostNew analysis provides additional data demonstrating differentiation of NCX 470Development activities on track for U.S. New Drug Application submission targeted in H1 2026March 3, 2025 – release at 7:30 am CETSophia Antipolis, France ...

Biot, 03/03/2025 (informazione.news - comunicati stampa - salute e benessere)

 

 

Attachment